These studies are in active protocol development. They are not open yet, and there is nothing to apply to. You can register early interest, and we will reach out the moment a study you might fit opens for screening.
A research study moves through several stages before anyone can take part. These studies are at the earliest one.
Until a study clears ethics review and is registered, key details are not final. Those are who can join, what is involved, timing, and compensation. We do not publish them yet.
1Protocol developmentyou are here
2IRB review
3Registered on ClinicalTrials.gov
4Open — recruiting
Not open yet — and not yet an application. Registering interest does not put you in a study and does not decide whether a study is a fit.
The studies
In Development
Young Adult Study — Psilocybin for Treatment-Resistant OCD
A forthcoming study of psilocybin-assisted therapy in a young adult population. What the study asks for, when it opens, and study design details will be posted as the protocol is finalized.
Group Study — Psilocybin for a Psychiatric Condition (TBD)
A group-format study in development at ENACT, with non-directive support, run in person at Yale. Target condition, what the study asks for, dosing, group structure, timeline and compensation are still being finalised.
Caring for a young adult with treatment-resistant OCD, or a patient who might suit a future study? You can register their interest now so they are considered as soon as a relevant study opens.
Leave your name and we will contact you when a study you choose opens for screening. It does not reserve a place and it does not decide if a study is a fit.